February 1, 2017 / 1:28 PM / 3 years ago

BRIEF-Albireo announces submission of new drug application for Elobixibat in Japan

Feb 1 (Reuters) - Albireo Pharma Inc

* Albireo announces submission of new drug application for Elobixibat in Japan

* EA Pharma plans to co-market Elobixibat in Japan with Mochida Pharmaceutical Co., Ltd Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below